Compounds in fenugreek, however, have the potential to exacerbate hormone-sensitive cancers and induce uterine contractions during pregnancy when used or consumed. Additionally, fenugreek may result in moderate gastrointestinal problems including bloating and diarrhea. At least four fenugreek components have been found to have antidiabetic qualities in a number of animal experiments. They principally lessen the absorption of glucose from the intestines, postpone the emptying of the stomach, enhance insulin sensitivity and activity, and lower lipid-binding protein concentrations. Nevertheless, the mice fed a low-fat diet did not see an improvement in glucose tolerance when given fenugreek. Additionally, the authors found that fenugreek was not as efficient as four days of voluntary exercise on a spinning wheel in boosting the mice’s glucose tolerance. Overall, fenugreek proved to have less health benefits than the researchers had anticipated.
